
| ROI Name | ∑ In  | % In  | log ratio  | ∑ Out  | % Out  | 
|---|---|---|---|---|---|
| EB | 5,737 | 91.0% | 0.53 | 8,296 | 97.3% | 
| CRE_L | 451 | 7.2% | -1.91 | 120 | 1.4% | 
| MB_ML_L | 46 | 0.7% | 0.65 | 72 | 0.8% | 
| MB_ML_R | 36 | 0.6% | -1.00 | 18 | 0.2% | 
| GA_L | 23 | 0.4% | -2.52 | 4 | 0.0% | 
| AVLP_L | 9 | 0.1% | 0.74 | 15 | 0.2% | 
| MB_PED_L | 3 | 0.0% | -0.58 | 2 | 0.0% | 
| FB | 1 | 0.0% | -inf | 0 | 0.0% | 
| upstream partner  | # | NT | conns ER3m  | % In  | CV | 
|---|---|---|---|---|---|
| ER3m (L) | 8 | GABA | 194.8 | 28.3% | 0.2 | 
| ER3m (R) | 7 | GABA | 168.4 | 24.4% | 0.2 | 
| ER3a_a,ER3a_d (L) | 11 | GABA | 91.5 | 13.3% | 0.3 | 
| ER3a_a,ER3a_d (R) | 12 | GABA | 88.5 | 12.8% | 0.3 | 
| TuBu02 (L) | 5 | ACh | 28.2 | 4.1% | 0.2 | 
| EL (L) | 8 | GABA | 16 | 2.3% | 0.3 | 
| ER3d (R) | 20 | GABA | 14 | 2.0% | 1.9 | 
| ER3d (L) | 22 | GABA | 13.8 | 2.0% | 1.7 | 
| EL (R) | 8 | GABA | 9.8 | 1.4% | 0.3 | 
| ER3p_a (L) | 9 | GABA | 8.8 | 1.3% | 0.9 | 
| ExR1 (L) | 2 | GABA | 7.4 | 1.1% | 0.2 | 
| ExR1 (R) | 2 | Unk | 7.2 | 1.1% | 0.1 | 
| ER3p_a (R) | 8 | GABA | 5.8 | 0.8% | 0.7 | 
| ER3p_b (L) | 3 | GABA | 5.1 | 0.7% | 0.4 | 
| ExR3 (R) | 1 | DA | 3.9 | 0.6% | 0.0 | 
| PFGs (L) | 5 | 5-HT | 3.8 | 0.5% | 0.5 | 
| ER3a_b,ER3a_c (L) | 7 | GABA | 3.8 | 0.5% | 0.6 | 
| ER3a_b,ER3a_c (R) | 7 | GABA | 3.5 | 0.5% | 0.7 | 
| ExR3 (L) | 1 | Unk | 2.2 | 0.3% | 0.0 | 
| ER3p_b (R) | 2 | GABA | 1.6 | 0.2% | 0.2 | 
| ER2 (L) | 8 | GABA | 1.5 | 0.2% | 0.5 | 
| ER2 (R) | 7 | GABA | 1.5 | 0.2% | 0.3 | 
| ER3w (R) | 7 | GABA | 1.4 | 0.2% | 0.7 | 
| EPG (R) | 7 | ACh | 1.1 | 0.2% | 0.4 | 
| EPG (L) | 6 | ACh | 0.9 | 0.1% | 0.3 | 
| ER1 (R) | 2 | GABA | 0.8 | 0.1% | 0.7 | 
| ExR2_2 (L) | 1 | DA | 0.5 | 0.1% | 0.0 | 
| FB4L (L) | 2 | Unk | 0.5 | 0.1% | 0.0 | 
| ER4d (L) | 3 | GABA | 0.5 | 0.1% | 0.4 | 
| FB1C (L) | 1 | Unk | 0.2 | 0.0% | 0.0 | 
| ER1 (L) | 2 | GABA | 0.2 | 0.0% | 0.0 | 
| ER4m (L) | 2 | GABA | 0.2 | 0.0% | 0.0 | 
| ER3w (L) | 1 | GABA | 0.2 | 0.0% | 0.0 | 
| ER5 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 | 
| ER6 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 | 
| CB3890 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 | 
| CB2469 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 | 
| SMP292,SMP293,SMP584 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 | 
| PEG (L) | 1 | ACh | 0.1 | 0.0% | 0.0 | 
| ExR2_1 (R) | 1 | DA | 0.1 | 0.0% | 0.0 | 
| TuBu05 (L) | 1 | ACh | 0.1 | 0.0% | 0.0 | 
| ExR2_1 (L) | 1 | DA | 0.1 | 0.0% | 0.0 | 
| FB1G (R) | 1 | ACh | 0.1 | 0.0% | 0.0 | 
| MBON06 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 | 
| downstream partner  | # | NT | conns ER3m  | % Out  | CV | 
|---|---|---|---|---|---|
| ER3m (L) | 8 | GABA | 194.8 | 25.9% | 0.2 | 
| ER3m (R) | 7 | GABA | 186.6 | 24.8% | 0.2 | 
| ExR1 (R) | 2 | Unk | 51 | 6.8% | 0.0 | 
| ER3a_a,ER3a_d (R) | 12 | GABA | 50 | 6.6% | 0.7 | 
| EPG (L) | 24 | ACh | 49.9 | 6.6% | 0.6 | 
| ExR1 (L) | 2 | GABA | 45.5 | 6.0% | 0.2 | 
| ER3a_a,ER3a_d (L) | 11 | GABA | 44.1 | 5.9% | 0.8 | 
| EPG (R) | 20 | ACh | 43.5 | 5.8% | 0.8 | 
| ER3d (R) | 18 | GABA | 18.4 | 2.4% | 1.8 | 
| ER3d (L) | 18 | GABA | 17.1 | 2.3% | 2.0 | 
| EL (L) | 8 | GABA | 8 | 1.1% | 0.4 | 
| ER3p_a (R) | 8 | GABA | 7.2 | 1.0% | 0.4 | 
| ER3p_a (L) | 9 | GABA | 5.2 | 0.7% | 0.7 | 
| PFGs (L) | 5 | 5-HT | 5.2 | 0.7% | 0.3 | 
| EL (R) | 7 | GABA | 4.2 | 0.6% | 0.4 | 
| ER2 (L) | 7 | GABA | 2.6 | 0.3% | 0.7 | 
| ER3p_b (L) | 3 | GABA | 2.5 | 0.3% | 0.2 | 
| ER3a_b,ER3a_c (L) | 6 | GABA | 2 | 0.3% | 0.2 | 
| ER2 (R) | 7 | GABA | 1.9 | 0.2% | 0.6 | 
| ER3w (R) | 6 | GABA | 1.9 | 0.2% | 1.3 | 
| ER1 (L) | 10 | GABA | 1.9 | 0.2% | 0.4 | 
| ER3a_b,ER3a_c (R) | 5 | GABA | 1.5 | 0.2% | 0.6 | 
| ER1 (R) | 4 | GABA | 1.2 | 0.2% | 0.8 | 
| ER3p_b (R) | 2 | GABA | 1.2 | 0.2% | 0.2 | 
| ExR3 (R) | 1 | DA | 0.6 | 0.1% | 0.0 | 
| TuBu02 (L) | 3 | ACh | 0.6 | 0.1% | 0.3 | 
| ER3w (L) | 5 | GABA | 0.6 | 0.1% | 0.0 | 
| FB2I_a (R) | 3 | Unk | 0.4 | 0.0% | 0.0 | 
| ExR2_2 (L) | 1 | DA | 0.2 | 0.0% | 0.0 | 
| FB1G (R) | 1 | ACh | 0.2 | 0.0% | 0.0 | 
| SMP292,SMP293,SMP584 (L) | 1 | ACh | 0.2 | 0.0% | 0.0 | 
| ExR3 (L) | 1 | Unk | 0.2 | 0.0% | 0.0 | 
| PEG (R) | 1 | ACh | 0.2 | 0.0% | 0.0 | 
| CRE103b (L) | 2 | ACh | 0.2 | 0.0% | 0.0 | 
| SIP028a (L) | 1 | GABA | 0.1 | 0.0% | 0.0 | 
| FB4K (R) | 1 | Unk | 0.1 | 0.0% | 0.0 | 
| ExR5 (R) | 1 | Glu | 0.1 | 0.0% | 0.0 | 
| CB1454 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 | 
| FB4K (L) | 1 | Unk | 0.1 | 0.0% | 0.0 | 
| ExR2_1 (L) | 1 | DA | 0.1 | 0.0% | 0.0 | 
| PFGs (R) | 1 | Glu | 0.1 | 0.0% | 0.0 | 
| hDeltaK (L) | 1 | 5-HT | 0.1 | 0.0% | 0.0 | 
| PEG (L) | 1 | ACh | 0.1 | 0.0% | 0.0 | 
| LAL123 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 | 
| PLP078 (L) | 1 | Glu | 0.1 | 0.0% | 0.0 | 
| ER4m (L) | 1 | GABA | 0.1 | 0.0% | 0.0 | 
| FB3B,FB3C,FB3E (L) | 1 | Glu | 0.1 | 0.0% | 0.0 | 
| LNO2 (L) | 1 | Unk | 0.1 | 0.0% | 0.0 | 
| CB2245 (L) | 1 | GABA | 0.1 | 0.0% | 0.0 | 
| FB4M (L) | 1 | DA | 0.1 | 0.0% | 0.0 |